CL2016000880A1 - Recubrimiento farmacéutico soluble en agua con estabilidad mejorada - Google Patents

Recubrimiento farmacéutico soluble en agua con estabilidad mejorada

Info

Publication number
CL2016000880A1
CL2016000880A1 CL2016000880A CL2016000880A CL2016000880A1 CL 2016000880 A1 CL2016000880 A1 CL 2016000880A1 CL 2016000880 A CL2016000880 A CL 2016000880A CL 2016000880 A CL2016000880 A CL 2016000880A CL 2016000880 A1 CL2016000880 A1 CL 2016000880A1
Authority
CL
Chile
Prior art keywords
coating
water soluble
improved stability
soluble pharmaceutical
molding
Prior art date
Application number
CL2016000880A
Other languages
English (en)
Inventor
Anwar Siraj Daud
Nidhi Prakash Sapkal
Minal Nandkumar Bonde
Original Assignee
Zim Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zim Laboratories Ltd filed Critical Zim Laboratories Ltd
Publication of CL2016000880A1 publication Critical patent/CL2016000880A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

<p>Un proceso/método para Ia preparación de un recubrimiento soluble en agua de rápida disolucion oral para Ia liberacion oral de un ingrediente activo, CARACTERIZADO porque el proceso comprende las etapas de moldear un recubrimiento que comprende polimero(s) soluble(s) en agua, aditivos opcionales; y secar el mismo mediante Ia aplicación de calor; en donde el secado del recubrimiento después del moldeado es realizado mediante incremento de Ia temperatura de secado en dos o más etapas, el proceso/método resulta en un recubrimiento con humedad estabilizada que permanece no-adherente y no-curvante cuando se expone a 70±5 % HR (Humedad Relativa) a 25°C por al menos 2 minutos hasta 2 horas en condiciones abiertas sin empaque.</p>
CL2016000880A 2013-10-14 2016-04-14 Recubrimiento farmacéutico soluble en agua con estabilidad mejorada CL2016000880A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3221MU2013 IN2013MU03221A (es) 2013-10-14 2014-10-13

Publications (1)

Publication Number Publication Date
CL2016000880A1 true CL2016000880A1 (es) 2017-01-27

Family

ID=53274239

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016000880A CL2016000880A1 (es) 2013-10-14 2016-04-14 Recubrimiento farmacéutico soluble en agua con estabilidad mejorada

Country Status (8)

Country Link
BR (1) BR112016008356B1 (es)
CA (1) CA2927334C (es)
CL (1) CL2016000880A1 (es)
EA (1) EA038558B1 (es)
IN (1) IN2013MU03221A (es)
MY (1) MY184297A (es)
UA (1) UA123893C2 (es)
WO (1) WO2015083181A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3082767B1 (en) * 2013-12-17 2024-09-25 Zim Laboratories Limited Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
MX2019010573A (es) * 2017-03-30 2019-10-24 Intelgenx Corp Metodo de tratamiento y dispositivo para la biodisponibilidad mejorada de antagonistas receptores de leucotrieno.
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
FR3082851B1 (fr) * 2018-06-25 2022-09-02 Biomerieux Sa Procede de detection et/ou d'identification d'au moins un microorganisme cible present sur une surface.
CN119015263A (zh) * 2024-08-20 2024-11-26 云南白药集团无锡药业有限公司 一种云南白药口溶膜剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5947987B2 (ja) * 1979-10-08 1984-11-22 富士写真フイルム株式会社 加筆・修正可能なマツトフイルム
US4664859A (en) * 1983-12-02 1987-05-12 Vcf Films Inc. Div. Of Pmc Process for solvent casting a film
US5272191A (en) * 1991-08-21 1993-12-21 Fmc Corporation Cold water soluble films and film forming compositions
US6966960B2 (en) * 2003-05-07 2005-11-22 Hewlett-Packard Development Company, L.P. Fusible water-soluble films for fabricating three-dimensional objects
WO2005084636A2 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited A process for the preparation of controlled-release pharmaceutical composition of metoprolol
WO2006080630A1 (en) * 2004-09-23 2006-08-03 Handok Pharmaceuticals Co., Ltd. Pharmaceutical combination preparation for oral delivery for the treatment of diabetes mellitus
US20090162516A1 (en) * 2007-12-21 2009-06-25 Brown Solomon E Edible, water-soluble film

Also Published As

Publication number Publication date
CA2927334A1 (en) 2015-06-11
CA2927334C (en) 2023-08-29
EA038558B1 (ru) 2021-09-14
EA201690751A1 (ru) 2016-08-31
WO2015083181A2 (en) 2015-06-11
WO2015083181A3 (en) 2015-12-03
IN2013MU03221A (es) 2015-07-03
BR112016008356A2 (pt) 2017-08-01
BR112016008356B1 (pt) 2022-12-13
UA123893C2 (uk) 2021-06-23
MY184297A (en) 2021-03-31

Similar Documents

Publication Publication Date Title
CL2016000880A1 (es) Recubrimiento farmacéutico soluble en agua con estabilidad mejorada
BR112018073703A2 (pt) emplastro para pele ou ferida, composição farmacêutica e método para a liberação de uma substância ativa
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
ECSP17078433A (es) Composiciones de ácido obeticólico y métodos de uso
MX2015012302A (es) Composiciones tópicas y métodos de tratamiento para trastornos de la piel.
MX2018003035A (es) Formulacion liquida de un dispositivo de vapor electronico.
DOP2017000162A (es) Forma de dosificación que incluye una solución sólida de drogas amorfas
UY35567A (es) ?derivados de 3-((2s,5s)-4-metilen-5-(3- oxopropil)tetrahidrofuran-2-il)propanol, su preparación e intermediarios útiles para la misma?.
BR112016006326A2 (pt) formulação seca de uma vacina, uso de uma formulação seca, método para fabricação de uma formulação seca, e, vacina
HK1214822A1 (zh) 新型 苄氧基 苯基 己- -炔酸衍生物、其製備方法、和包括其作為有效成分的用於預防和治療代謝性疾病的藥物組合物
WO2014052640A8 (en) Novel ampk agonist compositions and methods of use
NZ720328A (en) Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease
BR112018013011A2 (pt) composições de alimento para animais de estimação
BR112015028278A2 (pt) processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos
IN2012DE00337A (es)
MX2016011290A (es) Composiciones de ester de colina de acido lipoico y metodos de uso.
CR20150432A (es) Estra-1,3,5 (10), 16-tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
BR112015031417A8 (pt) forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem
BR112015030431A2 (pt) formulação de liberação modificada
FR2999086B1 (fr) Composition orale et/ou buccale sous forme de film fin d&#39;un principe actif faiblement soluble, son procede de preparation et son utilisation
BR112015018200A2 (pt) composição mastigável para administração oral e processo para preparar a mesma
BR112016002165A2 (pt) formulações compreendendo esfinganina
CL2016000182A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
CY1121708T1 (el) Ενωσεις ουριας ινδανυλιου που αναστελλουν την ρ38 map kιναση
BR112016018624A2 (pt) Artigo e método para sua fabricação